Compare DVAX & ALGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DVAX | ALGT |
|---|---|---|
| Founded | 1996 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Air Freight/Delivery Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.6B |
| IPO Year | 2004 | 2006 |
| Metric | DVAX | ALGT |
|---|---|---|
| Price | $15.63 | $90.16 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 5 | 9 |
| Target Price | $26.50 | ★ $91.44 |
| AVG Volume (30 Days) | ★ 5.6M | 419.9K |
| Earning Date | 02-19-2026 | 02-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $330,514,000.00 | ★ $2,578,095,000.00 |
| Revenue This Year | $24.63 | $5.11 |
| Revenue Next Year | $15.85 | $2.73 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 26.73 | 3.29 |
| 52 Week Low | $9.20 | $39.80 |
| 52 Week High | $15.73 | $107.57 |
| Indicator | DVAX | ALGT |
|---|---|---|
| Relative Strength Index (RSI) | 85.75 | 58.62 |
| Support Level | $15.57 | $84.01 |
| Resistance Level | $15.73 | $96.89 |
| Average True Range (ATR) | 0.06 | 3.60 |
| MACD | -0.05 | -0.69 |
| Stochastic Oscillator | 70.83 | 52.10 |
Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.
Allegiant Travel Co is a leisure travel company focused on providing travel and leisure services and products to residents of under-served cities in the United States. It operates a low-cost, low utilization passenger airline marketed to leisure travelers in under-served cities, allowing it to sell air transportation both on a stand-alone basis and bundled with the sale of air-related and third-party services and products. In addition, it provides air transportation under fixed-fee flight arrangements. In connection with its leisure travel focus, the company has opened Sunseeker Resort Charlotte Harbor, equipped with several guestrooms and food and beverage outlets. The company's operating segments are the Airline, which generates maximum revenue, and Sunseeker Resort.